Ajay Goel, PhD
SAN FRANCISCO—The early detection of pancreatic ductal adenocarcinoma may soon be realized, based on the accuracy of microRNA-based liquid biopsy assays, according to new research.
By pairing cell-free and exosomal microRNAs (cf- and exo-miRNAs), senior investigator Ajay Goel, PhD, and his team have created a panel of 13 biomarkers with an accuracy of up to 97% for PDAC.
“Even in the earlier stages of PDAC, these markers are about 91% accurate. And when we use them